Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.6%1-day move

₹433.75

prior close

₹432.20

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.0+1.2+1.3+0.9-1.6-4.0-5.0-4.3-4.7-3.8-4.2-4.5——

Up moveDown movePending

AI summary

Biocon has disclosed a scheduled meeting with analysts and institutional investors as required under SEBI Listing Regulations. The company management will participate in the Investec US Pharma & Healthcare Bus Tour on June 3, 2026, in the USA. This is a group interaction format. The company has explicitly stated it will not disclose any Unpublished Price Sensitive Information (UPSI) during the meeting. The filing is dated May 27, 2026, and is signed by Rajesh U. Shanoy, Company Secretary and Compliance Officer.

Likely market impact

This is a routine compliance filing with no material impact on the stock. It simply informs the market about a scheduled investor interaction, with the company reassuring that no price-sensitive information will be shared.